Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.9M Buy
47,946
+3,348
+8% +$1.19M 0.57% 46
2025
Q4
$14.6M Buy
44,598
+641
+1% +$203K 0.49% 49
2025
Q3
$12.4M Sell
43,957
-8,548
-16% -$2.48M 0.42% 56
2025
Q2
$14.7M Sell
52,505
-166
-0.3% -$47K 0.55% 50
2025
Q1
$16.4M Sell
52,671
-4,395
-8% -$1.3M 0.66% 42
2024
Q4
$14.9M Buy
57,066
+1,444
+3% +$428K 0.56% 52
2024
Q3
$17.9M Sell
55,622
-976
-2% -$319K 0.69% 39
2024
Q2
$17.7M Sell
56,598
-1,507
-3% -$443K 0.73% 33
2024
Q1
$16.5M Buy
58,105
+12,777
+28% +$3.74M 0.67% 39
2023
Q4
$13.1M Sell
45,328
-1,317
-3% -$359K 0.57% 49
2023
Q3
$12.5M Sell
46,645
-789
-2% -$197K 0.6% 48
2023
Q2
$10.5M Sell
47,434
-739
-2% -$171K 0.49% 59
2023
Q1
$11.6M Buy
48,173
+1,855
+4% +$455K 0.62% 48
2022
Q4
$12.2M Sell
46,318
-113
-0.2% -$30.3K 0.64% 48
2022
Q3
$10.5M Buy
46,431
+1,729
+4% +$419K 0.61% 51
2022
Q2
$10.9M Buy
44,702
+10,741
+32% +$2.63M 0.61% 53
2022
Q1
$8.21M Buy
33,961
+196
+0.6% +$45K 0.43% 78
2021
Q4
$7.6M Buy
33,765
+7,786
+30% +$1.64M 0.4% 82
2021
Q3
$5.52M Sell
25,979
-307
-1% -$70.7K 0.33% 89
2021
Q2
$6.41M Sell
26,286
-5,072
-16% -$1.25M 0.39% 81
2021
Q1
$7.8M Sell
31,358
-16,712
-35% -$3.99M 0.51% 60
2020
Q4
$11.1M Buy
48,070
+1,116
+2% +$257K 0.76% 42
2020
Q3
$11.9M Buy
46,954
+1,427
+3% +$354K 0.93% 29
2020
Q2
$10.7M Buy
45,527
+732
+2% +$167K 0.91% 31
2020
Q1
$9.08M Sell
44,795
-4,437
-9% -$969K 0.91% 32
2019
Q4
$11.9M Buy
49,232
+730
+2% +$161K 0.96% 26
2019
Q3
$9.39M Buy
48,502
+898
+2% +$172K 0.84% 36
2019
Q2
$8.77M Sell
47,604
-1,297
-3% -$232K 0.82% 35
2019
Q1
$9.29M Buy
48,901
+351
+0.7% +$67K 0.93% 29
2018
Q4
$9.45M Buy
48,550
+6,196
+15% +$1.21M 1.05% 23
2018
Q3
$8.78M Buy
42,354
+552
+1% +$109K 0.89% 28
2018
Q2
$7.72M Buy
41,802
+1,643
+4% +$291K 0.85% 29
2018
Q1
$6.85M Buy
40,159
+2,961
+8% +$544K 0.78% 34
2017
Q4
$6.47M Buy
37,198
+2,925
+9% +$518K 0.71% 36
2017
Q3
$6.39M Buy
34,273
+1,244
+4% +$220K 0.74% 36
2017
Q2
$5.69M Buy
33,029
+528
+2% +$85.9K 0.7% 38
2017
Q1
$5.33M Buy
32,501
+433
+1% +$71.9K 0.69% 36
2016
Q4
$4.69M Sell
32,068
-835
-3% -$126K 0.66% 38
2016
Q3
$5.49M Sell
32,903
-1,103
-3% -$187K 0.83% 32
2016
Q2
$5.17M Sell
34,006
-959
-3% -$149K 0.79% 35
2016
Q1
$5.24M Sell
34,965
-828
-2% -$123K 0.8% 35
2015
Q4
$5.81M Buy
35,793
+1,950
+6% +$307K 0.92% 26
2015
Q3
$4.68M Sell
33,843
-3,340
-9% -$526K 0.8% 34
2015
Q2
$5.71M Buy
37,183
+1,084
+3% +$174K 0.92% 31
2015
Q1
$5.77M Buy
36,099
+3,284
+10% +$517K 0.99% 29
2014
Q4
$5.23M Buy
32,815
+1,471
+5% +$229K 0.93% 31
2014
Q3
$4.4M Buy
31,344
+2,066
+7% +$270K 0.83% 36
2014
Q2
$3.47M Buy
29,278
+2,003
+7% +$232K 0.67% 51
2014
Q1
$3.36M Buy
27,275
+155
+0.6% +$18.8K 0.6% 54
2013
Q4
$3.09M Buy
27,120
+184
+0.7% +$20.9K 0.56% 54
2013
Q3
$3.02M Sell
26,936
-641
-2% -$69.5K 0.59% 51
2013
Q2
$2.72M Buy
+27,577
New +$2.86M 0.56% 55

Other funds holding AMGN

First National Trust's AMGN Position: Q1 2026 in Review

First National Trust increased its Amgen (AMGN) stake by 7.5% in Q1 2026, buying an estimated $1.19M and bringing the position to 47,946 shares worth $16.9M. The position accounts for 0.57% of the portfolio, ranked #46.

First National Trust first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $17.9M in Q3 2024. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • First National Trust held 47,946 shares of Amgen worth $16.9M as of Q1 2026.
  • First National Trust bought 3,348 Amgen shares in Q1 2026, an estimated $1.19M.
  • Amgen made up 0.57% of First National Trust's portfolio in Q1 2026, its #46 holding.
  • First National Trust first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • First National Trust's Amgen position peaked at $17.9M in Q3 2024.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on First National Trust's 13F filing for Q1 2026, filed 7 May 2026.